Immunisation against hepatitis B in Taiwan.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8786059.
- Also identified by PMC identifier 1398048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hepatitis B is hyperendemic in Taiwan; more than 15% of adults are chronic carriers of the virus and longterm sequelae (chronic active hepatitis, cirrhosis, and hepatocellular carcinoma) are common. A national immunisation programme was implemented in 1984 to tackle the problem. This entailed immunisation of newborn children, followed by susceptible school children and young adults. The programme, which has been in place for a decade, has resulted in a pronounced reduction in the prevalence of HBsAg among young children and seems to have led to a reduction in horizontal transmission among older children.
Medical subject headings
- Hepatitis B
- Hepatitis B Vaccines
- Immunization Programs